Hypertriglyceridemia and coronaryheart disease risk

Area of Science:

• Cardiology
• Metabolic Disorders
• Lipidology

Background:

• Triglyceride remnant particles correlate with coronary stenosis progression.
• Triglycerides are independently associated with coronary heart disease (CHD) risk, even when accounting for HDL cholesterol.
• Understanding plasma triglycerides requires considering other lipoproteins and fasting/postprandial levels.

Purpose of the Study:

• To present a clinical approach for managing hypertriglyceridemia.
• To address the empirical nature of current triglyceride-lowering recommendations.
• To highlight the need for evidence-based strategies in hypertriglyceridemia management.

Main Methods:

• Review of angiographic-based trials and prospective studies on triglycerides and cardiovascular risk.
• Analysis of the role of plasma triglycerides in the context of other lipoproteins.
• Discussion of fasting and postprandial triglyceride level implications.

Main Results:

• Established association between triglyceride remnant particles and coronary stenosis progression.
• Demonstrated independent association of triglycerides with CHD risk.
• Identified a lack of robust randomized clinical trial data for triglyceride-lowering therapies in CHD prevention.

Conclusions:

• Current recommendations for triglyceride lowering are largely empirical.
• A clinical approach to hypertriglyceridemia management is presented.
• Further research and clinical trials are needed to guide triglyceride-lowering therapies for CHD prevention.